✦ LIBER ✦

Dose–response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy

✍ Scribed by Zhen Zhang; Zhongxing Liao; Jing Jin; Jaffer Ajani; Joe Y. Chang; Melenda Jeter; Thomas Guerrero; Craig W. Stevens; Stephen Swisher; Linus Ho; James Yao; Pamela Allen; James D. Cox; Ritsuko Komaki

Book ID: 108148434
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 136 KB
Volume: 61
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2004.06.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concurrent low-dose cisplatin and thorac

Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter

✍ O. Pradier; K. Lederer; A. Hille; E. Weiss; H. Christiansen; H. Schmidberger; C. 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 261 KB

2136 Does concurrent chemotherapy improv

2136 Does concurrent chemotherapy improve local control and survival over radiotherapy alone or induction chemotherapy in stage III non-small cell lung cancer (NSCLC)? Results at 3 years in 140 patients (PTS) with a minimum follow-up of 24 months

✍ F. Reboul; Y. Brewer; P. Vincent; B. Chauvet; C.Félix Faure; M. Taulelle 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 133 KB